project id: TCGA-COAD; case submitter id: TCGA-AY-5543; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 65; days to birth: -23870; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1945; age at diagnosis: 23870; ajcc pathologic m: M1; ajcc pathologic n: N1a; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1004.0; icd 10 code: C18.2; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ascending colon; synchronous malignancy: No; tissue or organ of origin: Ascending colon; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.7; longest dimension: 0.8; oct embedded: No; shortest dimension: 0.3; portion submitter id: TCGA-AY-5543-01A-01; percent necrosis: 3.0; percent normal cells: 15.0; percent stromal cells: 10.0; percent tumor cells: 82.0; percent tumor nuclei: 80.0;